AbCellera Biologics (ABCL) Earnings Date, Estimates & Call Transcripts $2.83 +0.04 (+1.43%) (As of 09:08 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AbCellera Biologics Latest Earnings SummaryActual EPS (Nov. 4) -$0.17 Missed By -$0.03 Consensus EPS (Nov. 4) -$0.14 AbCellera Biologics posted Q3 2024 earnings on November 4, 2024, reporting an EPS of -$0.17, which missed the consensus estimate of -$0.14 by $0.03. Quarterly revenue was reported to be $6.51 million, below the consensus estimate of $8.95 million. With a trailing EPS of -$0.61, AbCellera Biologics' earnings are expected to decrease next year, from ($0.59) to ($0.71) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by Get AbCellera Biologics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AbCellera Biologics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataABCL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABCL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AbCellera Biologics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.14-$0.08-$0.11Q2 20243-$0.15-$0.09-$0.13Q3 20243-$0.14-$0.05-$0.09Q4 20243-$0.15-$0.09-$0.11FY 202412-$0.58-$0.31-$0.45Q1 20251-$0.15-$0.15-$0.15Q2 20251-$0.15-$0.15-$0.15Q3 20251-$0.16-$0.16-$0.16Q4 20251-$0.17-$0.17-$0.17FY 20254($0.63)($0.63)($0.63) AbCellera Biologics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/4/2024Q3 2024-$0.14-$0.17 -$0.03-$0.17$8.95M$6.51M8/6/2024Q2 2024-$0.15-$0.13+$0.02-$0.13$10.12M$7.30M5/7/2024Q1 2024-$0.16-$0.14+$0.02-$0.14$10.73M$9.95M2/20/2024Q4 2023-$0.14-$0.17 -$0.03-$0.17$9.58M$9.18M11/2/2023Q3 2023-$0.14-$0.10+$0.04-$0.10$11.92M$6.60M8/3/2023Q2 2023-$0.13-$0.11+$0.02-$0.11$12.38M$10.10M Get the Latest News and Ratings for ABCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023Q1 2023-$0.12-$0.14 -$0.02-$0.14$12.11M$12.20M2/21/2023Q4 2022$0.01-$0.10 -$0.11-$0.10$50.80M$21.50M AbCellera Biologics Earnings - Frequently Asked Questions When did AbCellera Biologics announce their last quarterly earnings? AbCellera Biologics (NASDAQ:ABCL) last announced its quarterly earning data on Monday, November 4, 2024. Learn more on ABCL's earnings history. Did AbCellera Biologics beat their earnings estimates last quarter? In the previous quarter, AbCellera Biologics (NASDAQ:ABCL) missed the analysts' consensus estimate of ($0.14) by $0.03 with a reported earnings per share (EPS) of ($0.17). Learn more on analysts' earnings estimate vs. ABCL's actual earnings. How can I listen to AbCellera Biologics's earnings conference call? The conference call for AbCellera Biologics's latest earnings report can be listened to online. Listen to Conference Call How can I read AbCellera Biologics's conference call transcript? The conference call transcript for AbCellera Biologics's latest earnings report can be read online. Read Transcript How much revenue does AbCellera Biologics generate each year? AbCellera Biologics (NASDAQ:ABCL) has a recorded annual revenue of $32.96 million. How much profit does AbCellera Biologics generate each year? AbCellera Biologics (NASDAQ:ABCL) has a recorded net income of -$146.40 million. ABCL has generated -$0.61 earnings per share over the last four quarters. What is AbCellera Biologics's EPS forecast for next year? AbCellera Biologics's earnings are expected to decrease from ($0.59) per share to ($0.71) per share in the next year. More Earnings Resources from MarketBeat Related Companies MoonLake Immunotherapeutics Earnings Results Edgewise Therapeutics Earnings Results Janux Therapeutics Earnings Results Xenon Pharmaceuticals Earnings Results Amicus Therapeutics Earnings Results Merus Earnings Results ACADIA Pharmaceuticals Earnings Results MorphoSys Earnings Results Zai Lab Earnings Results Vera Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now This page (NASDAQ:ABCL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
